Zenas BioPharma closes upsized $200 million Series C financing led by SR One, NEA, Norwest Venture Partners, and Delos Capital
Amount Raised
$200 Million
Round Type
Series C
WalthamBiotechnologyHealth CareTherapeuticsInvestors
Description
Zenas BioPharma announced the closing of an upsized $200 million Series C preferred stock financing to support ongoing mid-to-late-stage clinical development programs for their lead product candidate, obexelimab.
Quick answer
Zenas BioPharma raised $200 Million in a Series C round, dated May 7, 2024. Investors: New Enterprise Associates, Delos Capital, Norwest Venture Partners and SR One. Zenas BioPharma is based in Waltham, Massachusetts, United States.
- How much did Zenas BioPharma raise?
- Zenas BioPharma raised $200 Million in a Series C round on May 7, 2024.
- Who invested in Zenas BioPharma?
- New Enterprise Associates, Delos Capital, Norwest Venture Partners and SR One are named as investors in this round.
- What does Zenas BioPharma do?
- Zenas BioPharma is a global biopharmaceutical company committed to becoming a leader in the development and commercialization of inflammation and immunology (I&I) directed therapies for patients in need around the world.
- Where is Zenas BioPharma based and how big is it?
- Zenas BioPharma is based in Waltham, Massachusetts, United States. Fundz records about 122 employees.
- Who are the decision-makers at Zenas BioPharma?
- Fundz holds 1 contact at Zenas BioPharma. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Zenas BioPharma that raised within 45 days of this round, from Fundz verified event records.
- āshibio raised $40M (Series A) on June 20, 2024.
- iOnctura BV raised $86M (Series B) on June 20, 2024.
- Autobahn Therapeutics raised $101M on June 20, 2024.
- Mustang Bio raised $2.5M on June 19, 2024.
- Canton Strategic Holdings, Inc. raised $2.1M on June 18, 2024.
- InduPro raised $85M (Series A) on June 13, 2024.
Who to call at Zenas BioPharma, and when
A new round usually means Zenas BioPharma is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Zenas BioPharma raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Zenas BioPharma, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Zenas BioPharma. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Zenas BioPharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Zenas BioPharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.